Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer discovery

Showing results (341-350 of 4,675) with videos related to

Pageof 468
Sort By:
Cancer Discovery|April 29, 2017
Analysis of Circulating Cell-Free DNA Identifies Multiclonal Heterogeneity of <i>BRCA2</i> Reversion Mutations Associated with Resistance to PARP InhibitorsDavid Quigley, Joshi J Alumkal, Alexander W Wyatt, et al.
Cancer Discovery|July 8, 2017
Novel Mitochondrial Mechanisms of Cytarabine Resistance in Primary AML CellsAaron D Schimmer
Cancer Discovery|May 25, 2017
Brigatinib Approved, but Treatment Role Uncertain
Cancer Discovery|May 27, 2017
Immune Atlases Created for Kidney, Lung Cancers
Cancer Discovery|June 29, 2017
FDA Partners with ASCO's CancerLinQ
Cancer Discovery|June 3, 2018
ERBB Signaling Interrupted: Targeting Ligand-Induced Pathway ActivationFrederick H Wilson, Katerina Politi
Cancer Discovery|June 7, 2018
Pembrolizumab Monotherapy for NSCLC Extends Survival
Cancer Discovery|June 17, 2018
Antibiotics Protect against Liver Tumors in Mice
Cancer Discovery|July 4, 2018
Pembrolizumab OK'd for Cervical Cancer
Cancer Discovery|July 4, 2018
Macropinocytosis Fuels Prostate CancerCosimo Commisso, Jayanta Debnath
Pageof 468

Showing results (341-350 of 4,675) with videos related to

Sort By:
Pageof 468
Cancer Discovery|April 29, 2017
Analysis of Circulating Cell-Free DNA Identifies Multiclonal Heterogeneity of <i>BRCA2</i> Reversion Mutations Associated with Resistance to PARP InhibitorsDavid Quigley, Joshi J Alumkal, Alexander W Wyatt, et al.
Cancer Discovery|July 8, 2017
Novel Mitochondrial Mechanisms of Cytarabine Resistance in Primary AML CellsAaron D Schimmer
Cancer Discovery|May 25, 2017
Brigatinib Approved, but Treatment Role Uncertain
Cancer Discovery|May 27, 2017
Immune Atlases Created for Kidney, Lung Cancers
Cancer Discovery|June 29, 2017
FDA Partners with ASCO's CancerLinQ
Cancer Discovery|June 3, 2018
ERBB Signaling Interrupted: Targeting Ligand-Induced Pathway ActivationFrederick H Wilson, Katerina Politi
Cancer Discovery|June 7, 2018
Pembrolizumab Monotherapy for NSCLC Extends Survival
Cancer Discovery|June 17, 2018
Antibiotics Protect against Liver Tumors in Mice
Cancer Discovery|July 4, 2018
Pembrolizumab OK'd for Cervical Cancer
Cancer Discovery|July 4, 2018
Macropinocytosis Fuels Prostate CancerCosimo Commisso, Jayanta Debnath
Pageof 468